3don MSN
Oklahoma Children's Hospital debuts targeted chemo for rare eye cancer, treats first child in state
Oklahoma Children's Hospital is pioneering a targeted chemotherapy treatment for retinoblastoma, a rare eye cancer in ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Ocular adnexal tumors are relatively rare but require unique diagnostic and treatment considerations given the functional importance of the eye and periocular structures and their unique metastatic ...
The Hearty Soul on MSN
Doctors can spot diabetes and cancer in your eyes. Are you missing the signs?
The human eye is often described metaphorically as the "window to the soul," but in clinical medicine, it is more accurately viewed as a non-invasive window into the human body's circulatory and ...
A novel clinical tool discovered to predict patients’ response to therapy. Scientists took patient cells, expanded them, and reinfused back into patient to target cancer. Adoptive T cell therapy ...
Eye experts at Flinders University have released new global findings that reveal how a rare eye cancer first appears, offering vital insights that will help doctors diagnose the disease earlier and ...
University of Pittsburgh Medical Center researchers found a way to predict when a rare eye cancer will respond to treatment, The Washington Post reported April 22. The study, published in Nature ...
Six years ago, 66-year-old Ron White, a retired civilian airfield manager from Lacey, Washington, went to the optometrist for a routine appointment. There, his doctor noticed a tiny spot in the back ...
Malignant and premalignant ocular surface tumors (OSTs) can be sight- and life-threatening, potentially leading to vision loss, cosmetic disfigurement, severe morbidity, and even death. Early ...
Why are clinical trials in radiation oncology important? If you or a loved one is going through treatment for cancer, you may have wondered about clinical trials. How do they benefit patients? How ...
A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface malignancies in a small case series. The drug appeared fairly safe, although with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results